Lisata TherapeuticsLSTA
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 21 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were BML Capital Management, LLC ($848K), Vanguard Group Inc. ($555K) and Renaissance Technologies ($302K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $69K |
| Exits | 1 | $33K |
All 13F filers, Q3 2024 → Q4 2024: 32,457 shares bought and 13,446 shares sold, net +19,011 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| BML Capital Management, LLC | 0.53% | No change | 284,669 | $848K |
| Vanguard Group Inc. | 0.00% | No change | 186,366 | $555K |
| Renaissance Technologies | 0.00% | Reduce -2.2% | 101,322 | $302K |
| BlackRock, Inc. | 0.00% | No change | 56,013 | $167K |
| Geode Capital Management, LLC | 0.00% | Add +0.4% | 55,895 | $167K |
| Dimensional Fund Advisors LP | 0.00% | Add +45.5% | 25,226 | $75K |
| Citadel Advisors | 0.00% | New | 23,273 | $69K |
| State Street Corp. | 0.00% | No change | 14,348 | $43K |
| Bank of America Corp. | 0.00% | Add +7.2% | 10,410 | $31K |
| HighTower Advisors, LLC | 0.00% | No change | 10,042 | $30K |
| Cook Wealth, LLC | 0.01% | No change | 12,175 | $30K |
| Founders Capital Management | 0.00% | No change | 2,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +25.5% | 1,915 | $6K |
| Morgan Stanley | 0.00% | No change | 1,466 | $4K |
| SBI Securities Co., Ltd. | 0.00% | — | 540 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 15 | $45 |
| Barclays PLC | 0.00% | Reduce -42.9% | 4 | $12 |
| Wells Fargo & Company | 0.00% | No change | 1 | $3 |
| UBS Group AG | 0.00% | Reduce -99.2% | 1 | $3 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | No change | 52 | $0 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.